Postsurgical adjuvant therapy for melanoma. Evaluation of a 3-year randomized trial with recombinant interferon-alpha after 3 and 5 years of follow-up.

Autor: Rusciani, L, Petraglia, S, Alotto, M, Calvieri, S, Vezzoni, G
Zdroj: Cancer (0008543X); Jun1997, Vol. 79 Issue 12, p2354-2360, 7p
Databáze: Complementary Index
Externí odkaz: